LONDON – The European Union's medicines regulator will announce the conclusions of its investigation into the possible connection between AstraZeneca's coronavirus vaccine and rare blood clots later Wednesday.
Earlier this week, a senior official from the European Medicines Agency, or EMA, said there was a causal link between the AstraZeneca vaccine and the rare blood clots that have been seen in dozens of people worldwide, among the tens of millions who have received at least one dose.
Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency, said in comments to Rome’s Il Messaggero newspaper on Tuesday that “it is becoming more and more difficult to affirm that there isn’t a cause-and-effect relationship